跳至主要内容
临床试验/NCT03862469
NCT03862469已完成不适用

Premenstrual Hormonal and Affective State Evaluation (PHASE) Project

University of Illinois at Chicago2 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2019年9月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
129
试验地点
2
主要终点
Hormone Analysis

研究概览

简要总结

PHASE is designed to evaluate neuroactive hormone trajectories across the menstrual cycle and endocrine, autonomic, and subjective responses to psychosocial stress in women suffering from severe PMS (i.e., premenstrual dysphoric disorder).

详细描述

Female volunteers will be recruited from the community for participation in this 3-menstrual cycle study. In the first two menstrual cycles, study participants will chart their symptoms and and ovulation. Study participants will continue to perform ovulation testing during their third menstrual cycle in which they will attend one individualized task session and provide 8 serum samples at different timepoints across the menstrual cycle. Primary analyses will contrast neuroactive hormone trajectories across the menstrual cycle and stress reactivity according to study groups (PMDD vs healthy).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged 18-35 years, established by visual inspection of a government-issued ID
  • Average menstrual cycle 21-35 days

排除标准

  • Lifetime DSM-5 Axis 1 disorder (except anxiety and depression), as documented in the Mental Health Interview
  • Current DSM-5 Axis depressive or anxiety disorder, as documented in the Mental Health Interview
  • Positive urine drug screen test
  • Breath alcohol concentration >0.00%
  • Self-reported smoker or carbon monoxide concentration ≥ 6 ppm
  • Irregular menstrual cycle
  • Current pregnancy (urine test-verified) or lactation, or a plan to become pregnant
  • Moderate or high suicide risk
  • Shipley IQ (vocabulary standard score) > 80
  • Any prescription medications (including hormonal forms of birth control)

研究组 & 干预措施

All Participants

Other

干预措施: Individualized laboratory test (Procedure)

结局指标

主要结局

Hormone Analysis

时间窗: -20, +20, +30, +40, +50, +65, +90 minutes in the late luteal phase of the menstrual cycle (one day between -1 to -6 days of the subsequent menstrual cycle)

Cortisol

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ajna Hamidovic, PharmD, MS

Assistant Professor

University of Illinois at Chicago

研究点 (2)

Loading locations...

相似试验

Premenstrual Hormonal and Affective State Evaluation... | 临床试验